| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3071650 | Neurocirugía | 2007 | 9 Pages |
Abstract
Evaluation of 1p/19q allelic status by LOH analysis may provide useful information for guiding clinical and therapeutical decisions with high succes ratio. These results shown why patients with 1p/19q codeletion survive longer, because adjuvant alkylants adds further improvements to standard, surgery and radiotherapy, treatments.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
J.L. Gil-Salú, J. Almarcha, A. Nieto, J.F. RodrÃguez-Gutiérrez,